These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 37404183)

  • 1. Gut Colonization by ESBL-Producing Escherichia coli in Dogs Is Associated with a Distinct Microbiome and Resistome Composition.
    Stege PB; Hordijk J; Sandholt AKS; Zomer AL; Viveen MC; Rogers MRC; Salomons M; Wagenaar JA; Mughini-Gras L; Willems RJL; Paganelli FL
    Microbiol Spectr; 2023 Aug; 11(4):e0006323. PubMed ID: 37404183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caretaker knowledge, attitudes, and practices (KAP) and carriage of extended-spectrum beta-lactamase-producing E. coli (ESBL-EC) in children in Quito, Ecuador.
    Marusinec R; Kurowski KM; Amato HK; Saraiva-Garcia C; Loayza F; Salinas L; Trueba G; Graham JP
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):2. PubMed ID: 33407927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut colonisation by extended-spectrum β-lactamase-producing Escherichia coli and its association with the gut microbiome and metabolome in Dutch adults: a matched case-control study.
    Ducarmon QR; Zwittink RD; Willems RPJ; Verhoeven A; Nooij S; van der Klis FRM; Franz E; Kool J; Giera M; Vandenbroucke-Grauls CMJE; Fuentes S; Kuijper EJ
    Lancet Microbe; 2022 Jun; 3(6):e443-e451. PubMed ID: 35659906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome diversity and composition in individuals with and without extended-spectrum β-lactamase-producing Enterobacterales carriage: a matched case-control study in infectious diseases department.
    Boyd A; El Dani M; Ajrouche R; Demontant V; Cheval J; Lacombe K; Cosson G; Rodriguez C; Pawlotsky JM; Woerther PL; Surgers L
    Clin Microbiol Infect; 2024 Sep; 30(9):1154-1163. PubMed ID: 38527613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of antibiotic resistance gene profiles in gut microbiomes of infants at risk of eczema.
    Loo EXL; Zain A; Yap GC; Purbojati RW; Drautz-Moses DI; Koh YQ; Chong YS; Tan KH; Gluckman PD; Yap F; Eriksson JG; Tham E; Shek LP; Kjelleberg S; Schuster SC; Banerjee R; Lee BW
    BMC Infect Dis; 2020 Apr; 20(1):312. PubMed ID: 32345218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carriage and population genetics of extended spectrum β-lactamase-producing Escherichia coli in cats and dogs in New Zealand.
    Karkaba A; Hill K; Benschop J; Pleydell E; Grinberg A
    Vet Microbiol; 2019 Jun; 233():61-67. PubMed ID: 31176414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying
    Feng C; Wen P; Xu H; Chi X; Li S; Yu X; Lin X; Wu S; Zheng B
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31748247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carriage of antimicrobial resistant Escherichia coli in dogs: Prevalence, associated risk factors and molecular characteristics.
    Wedley AL; Dawson S; Maddox TW; Coyne KP; Pinchbeck GL; Clegg P; Nuttall T; Kirchner M; Williams NJ
    Vet Microbiol; 2017 Feb; 199():23-30. PubMed ID: 28110781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis.
    Worby CJ; Sridhar S; Turbett SE; Becker MV; Kogut L; Sanchez V; Bronson RA; Rao SR; Oliver E; Walker AT; Walters MS; Kelly P; Leung DT; Knouse MC; Hagmann SHF; Harris JB; Ryan ET; Earl AM; LaRocque RC
    Lancet Microbe; 2023 Oct; 4(10):e790-e799. PubMed ID: 37716364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome signatures of nursing home residents carrying Enterobacteria producing extended-spectrum β-lactamases.
    Le Bastard Q; Chapelet G; Birgand G; Hillmann BM; Javaudin F; Hayatgheib N; Bourigault C; Bemer P; De Decker L; Batard E; Lepelletier D; Montassier E
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):107. PubMed ID: 32665016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-Spectrum ß-Lactamase-Producing
    Aworh MK; Ekeng E; Nilsson P; Egyir B; Owusu-Nyantakyi C; Hendriksen RS
    Front Cell Infect Microbiol; 2022; 12():869314. PubMed ID: 35463650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-genome and resistome analysis of extended-spectrum ß-lactamase-producing Escherichia coli: A multi-setting epidemiological surveillance study from Malaysia.
    Dwiyanto J; Hor JW; Reidpath D; Su TT; Lee SWH; Ayub Q; Mustapha FB; Lee SM; Foo SC; Chong CW; Rahman S
    PLoS One; 2022; 17(3):e0265142. PubMed ID: 35271656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Hasan B; Laurell K; Rakib MM; Ahlstedt E; Hernandez J; Caceres M; Järhult JD
    Microb Drug Resist; 2016 Dec; 22(8):682-687. PubMed ID: 27007258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study.
    Mughini-Gras L; Dorado-García A; van Duijkeren E; van den Bunt G; Dierikx CM; Bonten MJM; Bootsma MCJ; Schmitt H; Hald T; Evers EG; de Koeijer A; van Pelt W; Franz E; Mevius DJ; Heederik DJJ;
    Lancet Planet Health; 2019 Aug; 3(8):e357-e369. PubMed ID: 31439317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
    Arnan M; Gudiol C; Calatayud L; Liñares J; Dominguez MÁ; Batlle M; Ribera JM; Carratalà J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):355-60. PubMed ID: 21052757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing
    Habibzadeh N; Peeri Doghaheh H; Manouchehri Far M; Alimohammadi Asl H; Iranpour S; Arzanlou M
    Microb Drug Resist; 2022 Sep; 28(9):921-934. PubMed ID: 36067095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing Escherichia coli among healthcare workers.
    Bassyouni RH; Gaber SN; Wegdan AA
    J Infect Dev Ctries; 2015 Mar; 9(3):304-8. PubMed ID: 25771469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome predictors of Escherichia coli sequence type 131 colonization and loss.
    Park DE; Aziz M; Koch BJ; Roach K; Clabots C; Johnson JR; Price LB; Liu CM
    EBioMedicine; 2024 Jan; 99():104909. PubMed ID: 38096689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for faecal colonisation with Escherichia coli producing extended-spectrum and plasmid-mediated AmpC β-lactamases in dogs.
    Belas A; Salazar AS; Gama LT; Couto N; Pomba C
    Vet Rec; 2014 Aug; 175(8):202. PubMed ID: 24943100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.